Department of Gastroenterology, Ankara University Faculty of Medicine, Ankara, Turkey.
Department of General Surgery, Ankara University Faculty of Medicine, Ankara, Turkey.
Turk J Gastroenterol. 2023 Feb;34(2):177-181. doi: 10.5152/tjg.2023.22724.
The aims of this study were to investigate biliary complications in liver transplant recipients with choledochocholedocho stomy anastomosis, to identify the risk factors for the development of such complications, and to evaluate the success of endoscopic approaches in liver transplant recipients.
Between January 2013 and May 2021, a total of 238 patients with liver diseases underwent liver transplantation: 174 recipients undergoing choledochocholedochostomy anastomosis were included in the analysis.
Their median age was 54.0 years. The median posttransplant follow-up period was 29 months. Hepatitis B virus infection (33%) was the most common indication for liver transplantation. Most patients (87%) received living donor liver transplantation. The overall prevalence of posttransplant biliary complications was 31%. Anastomotic biliary strictures were the most common biliary complications (72%), followed by biliary leakage (13%). The median time between endoscopic retrograde cholangiography and liver transplantation was 4 months, with a mean of 3 ± 1.6 sessions. Endoscopic retrograde cholangiography-guided drainage and balloon dilation with or without stent placement was the most common treatment modalities for recipients with biliary strictures. The overall success rate of endoscopic treatment modalities was 83.3%, with 65% of the recipients exhibiting complete biochemical and endoscopic responses. The response did not differ significantly between living donor liver transplantation and cadaveric donor liver transplant recipients (P > .05). Three recipients required revision surgery for biliary complication repair. Six patients died due to biliary sepsis.
Biliary stricture and leakages were the most common biliary complications after liver transplantation. Endoscopic treatment was successful in most recipients.
本研究旨在探讨行胆肠吻合术的肝移植受者的胆系并发症,确定发生此类并发症的危险因素,并评估内镜方法在肝移植受者中的应用效果。
2013 年 1 月至 2021 年 5 月,共有 238 例肝病患者接受了肝移植:174 例接受胆肠吻合术的受者纳入分析。
患者中位年龄为 54.0 岁。中位移植后随访时间为 29 个月。乙型肝炎病毒感染(33%)是肝移植最常见的适应证。大多数患者(87%)接受活体供肝移植。肝移植后胆系并发症的总体发生率为 31%。胆肠吻合口狭窄是最常见的胆系并发症(72%),其次是胆漏(13%)。内镜逆行胰胆管造影检查与肝移植之间的中位时间为 4 个月,平均 3±1.6 次。内镜逆行胰胆管造影引导下引流和球囊扩张联合或不联合支架置入是治疗胆系狭窄受者的最常见方法。内镜治疗方法的总体成功率为 83.3%,65%的受者出现完全的生化和内镜反应。活体供肝与尸体供肝移植受者之间的反应无显著差异(P>.05)。3 例受者因胆系并发症修复需要再次手术。6 例患者因胆系感染死亡。
胆肠吻合术后胆系狭窄和胆漏是最常见的胆系并发症。内镜治疗在大多数受者中是成功的。